Last quarter (Q ), Skye Bioscience's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Skye Bioscience's net income was $-5.03M. See Skye Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 34.74M	$ 34.74M	$ 12.11M	$ 7.85M	$ 6.29M	$ 6.63M
Operating Income	$ -34.89M	$ -34.74M	$ -12.11M	$ -7.85M	$ -6.29M	$ -6.63M
Net Non Operating Interest Income Expense	$ -1.19M	$ -806.30K	$ -1.16M	$ -790.32K	$ -706.36K	$ -1.00M
Other Income Expense	$ 1.66M	$ 1.28M	-	$ -117.95K	$ 436.27K	$ 8.69M
Pretax Income	$ -37.64M	$ -37.64M	$ -19.47M	$ -8.52M	$ -6.56M	$ 1.05M
Tax Provision	$ 3.60K	$ 3.60K	$ 6.74K	$ 2.10K	$ 1.60K	$ 1.60K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -38.28M	$ -37.64M	$ -19.48M	$ -8.52M	$ -6.56M	$ 1.05M
Basic EPS	$ -2.88	$ -5.37	$ -0.04	$ -0.02	$ -0.03	$ 0.01
Diluted EPS	$ -2.88	$ -5.37	$ -0.04	$ -0.02	$ -0.03	$ -0.05
Basic Average Shares	$ 1.93B	$ 7.01M	$ 555.27M	$ 406.60M	$ 230.75M	$ 135.15M
Diluted Average Shares	$ 1.93B	$ 7.01M	$ 555.27M	$ 406.60M	$ 231.42M	$ 169.56M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 34.74M	$ 34.74M	$ 12.11M	$ 7.85M	$ 6.29M	$ 6.63M
Interest Expense	-	-	-	-	$ 704.88K	$ 1.00M
Net Income From Continuing And Discontinued Operation	$ -37.64M	$ -37.64M	$ -19.48M	$ -8.52M	$ -6.56M	$ 1.05M
Normalized Income	$ -23.51M	$ -29.59M	-	-	$ -6.88M	$ -7.62M
Ebit	$ -36.38M	$ -36.73M	$ -18.81M	$ -7.73M	$ -5.85M	$ 2.05M
Ebitda	$ -35.92M	$ -36.28M	$ -18.21M	$ -7.10M	$ -5.85M	$ 2.06M

Currency in USD

Skye Bioscience Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing